Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (21-30 of 290) with videos related to

Pageof 29
Sort By:
Clinical Neurology and Neurosurgery|January 1, 1985
Multiple sclerosis: incorporation of results of laboratory techniques in the diagnosisC H Polman, J C Koetsier, E C Wolters
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Long-term follow-up of suspected though unconfirmed MSJ M Nielsen, B M J Uitdehaag, C H Polman
Journal of the Neurological Sciences|March 1, 1991
Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosisM M van Dongen, F W Bertelsmann, C H Polman
Clinical Neurology and Neurosurgery|January 1, 1986
Multiple sclerosis: incorporation of results of laboratory techniques in the diagnosisC H Polman, J C Koetsier, J Valk, et al.
Journal of the Neurological Sciences|January 1, 1996
The effect of the 21-aminosteroid U74006F on the clinical course of acute experimental allergic encephalomyelitisB M Uitdehaag, C H Polman, K Sontrop, et al.
European Journal of Clinical Nutrition|April 1, 2004
Multiple sclerosis and vitamin D: an updateB M VanAmerongen, C D Dijkstra, P Lips, et al.
Annals of Internal Medicine|October 1, 1990
Corticosteroids and bone massH E van der Wiel, C H Polman, J C Netelenbos
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Opticospinal multiple sclerosis: a pathogenetically distinct form?M J Eikelenboom, J Killestein, B M Uitdehaag, et al.
Drugs|February 1, 1995
Multiple sclerosis therapy. A practical guideB W van Oosten, L Truyen, F Barkhof, et al.
Drugs|November 7, 1998
Choosing drug therapy for multiple sclerosis. An updateB W van Oosten, L Truyen, F Barkhof, et al.
Pageof 29

Showing results (21-30 of 290) with videos related to

Sort By:
Pageof 29
Clinical Neurology and Neurosurgery|January 1, 1985
Multiple sclerosis: incorporation of results of laboratory techniques in the diagnosisC H Polman, J C Koetsier, E C Wolters
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Long-term follow-up of suspected though unconfirmed MSJ M Nielsen, B M J Uitdehaag, C H Polman
Journal of the Neurological Sciences|March 1, 1991
Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosisM M van Dongen, F W Bertelsmann, C H Polman
Clinical Neurology and Neurosurgery|January 1, 1986
Multiple sclerosis: incorporation of results of laboratory techniques in the diagnosisC H Polman, J C Koetsier, J Valk, et al.
Journal of the Neurological Sciences|January 1, 1996
The effect of the 21-aminosteroid U74006F on the clinical course of acute experimental allergic encephalomyelitisB M Uitdehaag, C H Polman, K Sontrop, et al.
European Journal of Clinical Nutrition|April 1, 2004
Multiple sclerosis and vitamin D: an updateB M VanAmerongen, C D Dijkstra, P Lips, et al.
Annals of Internal Medicine|October 1, 1990
Corticosteroids and bone massH E van der Wiel, C H Polman, J C Netelenbos
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Opticospinal multiple sclerosis: a pathogenetically distinct form?M J Eikelenboom, J Killestein, B M Uitdehaag, et al.
Drugs|February 1, 1995
Multiple sclerosis therapy. A practical guideB W van Oosten, L Truyen, F Barkhof, et al.
Drugs|November 7, 1998
Choosing drug therapy for multiple sclerosis. An updateB W van Oosten, L Truyen, F Barkhof, et al.
Pageof 29